Cancer Immunology Immunotherapy
Impact Factor Trend (2018–2026)
Clarivate IF trend for Cancer Immunology Immunotherapy
SCImago Journal Rank citation prestige weighting
148 papers with at least that number of citations each
Aims & Scope
Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions. The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
IMMUNOLOGY
ONCOLOGY
IMMUNOLOGY
ONCOLOGY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisCancer Immunology Immunotherapy (acronym: ciim, abbr: CANCER IMMUNOL IMMUN, ISSN: 0340-7004) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Berlin Heidelberg in United States since 1976. The periodical holds a Journal Impact Factor (JIF) of 5.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.805 (Q1), an H-index of 148.
The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 298 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,677 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics